Biondvax Pharmaceuticals Ltd - ADR
BVXV
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.97M
Close$
$1.86
37% upside
Current Fair Value
37% upsideUndervalued by 37% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.97 Million |
|---|---|
| Enterprise Value | $22.07 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.2 |
| Beta | 2.37 |
| Outstanding Shares | 3,380,000 |
Return
| Return on Equity | -109.44% |
|---|---|
| Return on Assets | 39.12% |
| Return on Invested Capital | -49.18% |
Valuation & Multiples
| P/E Ratio | -18.61 |
|---|---|
| PEG | 27.03 |
| Price to Sales | - |
| Price to Book Ratio | -0.45 |
| Enterprise Value to Revenue | 10.95 |
| Enterprise Value to EBIT | -2.49 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 1.12 |
| Debt to Equity | -3.46 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biondvax Pharmaceuticals Ltd
CEO: Ron Babecoff